Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Kinjo

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Internal Medicine (Tokyo, Japan)|September 23, 2020
Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19Hideta Nakamura, Kazuya Miyagi, Mariko Otsuki, et al.
Respiratory Investigation|October 17, 2020
Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case seriesHideta Nakamura, Kazuya Miyagi, Mariko Otsuki, et al.
Internal Medicine (Tokyo, Japan)|March 7, 2015
Acute respiratory distress syndrome due to Strongyloides stercoralis infection in a patient with cervical cancerTakeshi Kinjo, Daijiro Nabeya, Hideta Nakamura, et al.
Journal of Medical Virology|July 8, 2020
Serum KL-6 can distinguish between different phenotypes of severe COVID-19Hideta Nakamura, Kazuya Miyagi, Mariko Otsuki, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 19, 2024
Detection of community-acquired respiratory viruses during COVID-19 pandemic in subtropical region in JapanWakaki Kami, Takeshi Kinjo, Hiroe Hashioka, et al.
Emerging Microbes & Infections|July 10, 2019
Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profilesYuki Matsumoto, Takeshi Kinjo, Daisuke Motooka, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2009
Addison's disease due to tuberculosis that required differentiation from SIADHTakeshi Kinjo, Daisuke Higuchi, Yasuji Oshiro, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 23, 2016
Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literatureJun Hirai, Mao Hagihara, Shusaku Haranaga, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 30, 2016
Case-control study of pneumonia patients with Streptococcus anginosus group bacteria in their sputumJun Hirai, Daisuke Sakanashi, Shusaku Haranaga, et al.
European Journal of Immunology|November 25, 2003
Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infectionKazuyoshi Kawakami, Natsuo Yamamoto, Yuki Kinjo, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Internal Medicine (Tokyo, Japan)|September 23, 2020
Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19Hideta Nakamura, Kazuya Miyagi, Mariko Otsuki, et al.
Respiratory Investigation|October 17, 2020
Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case seriesHideta Nakamura, Kazuya Miyagi, Mariko Otsuki, et al.
Internal Medicine (Tokyo, Japan)|March 7, 2015
Acute respiratory distress syndrome due to Strongyloides stercoralis infection in a patient with cervical cancerTakeshi Kinjo, Daijiro Nabeya, Hideta Nakamura, et al.
Journal of Medical Virology|July 8, 2020
Serum KL-6 can distinguish between different phenotypes of severe COVID-19Hideta Nakamura, Kazuya Miyagi, Mariko Otsuki, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 19, 2024
Detection of community-acquired respiratory viruses during COVID-19 pandemic in subtropical region in JapanWakaki Kami, Takeshi Kinjo, Hiroe Hashioka, et al.
Emerging Microbes & Infections|July 10, 2019
Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profilesYuki Matsumoto, Takeshi Kinjo, Daisuke Motooka, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2009
Addison's disease due to tuberculosis that required differentiation from SIADHTakeshi Kinjo, Daisuke Higuchi, Yasuji Oshiro, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 23, 2016
Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literatureJun Hirai, Mao Hagihara, Shusaku Haranaga, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 30, 2016
Case-control study of pneumonia patients with Streptococcus anginosus group bacteria in their sputumJun Hirai, Daisuke Sakanashi, Shusaku Haranaga, et al.
European Journal of Immunology|November 25, 2003
Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infectionKazuyoshi Kawakami, Natsuo Yamamoto, Yuki Kinjo, et al.
Pageof 12